An Open-Label, Single-Center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer - Contacts and Locations

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

An Open-Label, Single-Center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer

This study is currently recruiting participants.

Study NCT00561197. Last updated on January 8, 2009.

Information provided by Ascenta Therapeutics

Please refer to this study by its ClinicalTrials.gov identifier: NCT00561197

Contacts

Contact: Kimberli Brill	610-725-1506	kbrill@ascenta.com
Contact: Lance Leopold, MD	610-408-0301	lleopold@ascenta.com

Locations

United States, Texas
MD Anderson Cancer Center	Recruiting
Houston, Texas, United States
Contact: Angela Welch 713-792-2172

Sponsors and Collaborators

Ascenta Therapeutics

Investigators

Study Director:

Lance Leopold, MD

Ascenta Therapeutics, Inc.